Cormorant Asset Management, LP Tarsus Pharmaceuticals, Inc. Transaction History

Cormorant Asset Management, LP

$628 Million
Q3 2025

A detailed history of Cormorant Asset Management, LP transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 300,000 shares of TARS stock, worth $21.7 Million. This represents 2.84% of its overall portfolio holdings.

Number of Shares

300,000

Previous 300,000 -0.0%

Holding current value

$21.7 Million

Previous $12.2 Million 46.7%

% of portfolio

2.84%

Previous 1.23%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$39.88 - $51.49 $3.99 Million - $5.15 Million	-100,000 Reduced 25.0%	300,000 $12.2 Million
Q1 2025 May 15, 2025	SELL	$41.29 - $56.94 $4.13 Million - $5.69 Million	-100,000 Reduced 20.0%	400,000 $20.5 Million
Q2 2024 Aug 14, 2024	SELL	$25.17 - $38.73 $41.3 Million - $63.5 Million	-1,639,102 Reduced 76.63%	500,000 $13.6 Million
Q1 2024 May 15, 2024	SELL	$19.61 - $39.22 $1.61 Million - $3.23 Million	-82,320 Reduced 3.71%	2,139,102 $77.8 Million
Q4 2023 Feb 14, 2024	SELL	$12.98 - $20.73 $5.19 Million - $8.29 Million	-400,000 Reduced 15.26%	2,221,422 $45 Million

Q3 2023 Nov 14, 2023	BUY	$14.75 - $24.62 $17.7 Million - $29.5 Million	1,200,000 Added 84.42%	2,621,422 $46.6 Million
Q1 2023 May 15, 2023	SELL	$11.92 - $16.27 $3.75 Million - $5.13 Million	-315,000 Reduced 18.14%	1,421,422 $17.9 Million
Q4 2022 Feb 14, 2023	SELL	$14.12 - $18.72 $3.32 Million - $4.4 Million	-235,000 Reduced 11.92%	1,736,422 $25.5 Million
Q3 2022 Nov 14, 2022	BUY	$14.08 - $18.5 $1.36 Million - $1.78 Million	96,422 Added 5.14%	1,971,422 $33.8 Million
Q2 2022 Aug 15, 2022	BUY	$11.08 - $19.08 $5.53 Million - $9.52 Million	499,018 Added 36.27%	1,875,000 $27.4 Million
Q1 2022 May 16, 2022	SELL	$14.49 - $24.28 $396,287 - $664,033	-27,349 Reduced 1.95%	1,375,982 $23.1 Million
Q4 2021 Feb 14, 2022	SELL	$21.21 - $29.68 $880,215 - $1.23 Million	-41,500 Reduced 2.87%	1,403,331 $31.6 Million
Q3 2021 Nov 15, 2021	SELL	$21.45 - $29.22 $1.49 Million - $2.03 Million	-69,438 Reduced 4.59%	1,444,831 $31.1 Million
Q2 2021 Aug 16, 2021	SELL	$27.16 - $38.59 $5.43 Million - $7.72 Million	-200,000 Reduced 11.67%	1,514,269 $43.9 Million
Q4 2020 Feb 16, 2021	BUY	$19.17 - $49.62 $32.9 Million - $85.1 Million	1,714,269 New	1,714,269 $70 Million

Others Institutions Holding TARS

# of Institutions

231

Shares Held

45M

Call Options Held

51.6K

Put Options Held

15.8K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.92B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account

Cormorant Asset Management, LP Tarsus Pharmaceuticals, Inc. Transaction History